Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Early Days For Discovery Collaborations With Academia In China - China Healthcare Investment Conference

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Big Pharma and device companies are looking to test different models to harness a new source of novel technology as China's innovative life science sectors become more developed. Returnees, Chinese researchers and entrepreneurs that study or work in the West before establishing or working for companies in China, may have a large impact on how Western firms approach partnering in China

You may also be interested in...



Medtronic Launches New Facilities In Shanghai And Singapore; Thermo Fisher To Open Fifth China Plant

Medtronic Inc. raised its Asian profile last week with opening ceremonies for a regional headquarters building in Shanghai and a manufacturing plant in Singapore. The company plans to add 1,000 skilled staff to its China workforce in the next five years

Lilly Shifts Gears In China With New Shanghai-based R&D Center

Eli Lilly is deepening its commitment to China and diabetics in the country by opening a new R&D center in Shanghai that aims to discover novel compounds that will lead to breakthrough therapies for diabetes

Pfizer Signs Academic Collaboration Pact With Peking University To Support Translational R&D Center In Shenzhen

SHANGHAI - After unveiling a plan to build a research and development center in Wuhan last week, Pfizer announced it inked an agreement with Peking University Dec. 1 to fund the university's research projects and to build a translational research and drug discovery center in PKU's Graduate School in Shenzhen, a Chinese city that borders the former British enclave of Hong Kong

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC077631

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel